Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

524 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Recruiting

A Study of PHN-012 in Patients With Advanced Solid Tumors

NCT07127874

Conditions
Advanced Cancer, Advanced Solid Tumors, Bronchial Neoplasms, +28 more
Locations
  • PHN-012-001 Site Los Angeles, California, United States
  • PHN-012-001 Site San Diego, California, United States
  • PHN-012-001 Site Washington D.C., District of Columbia, United States
  • PHN-012-001 Site Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Recruiting

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

NCT06445114

Conditions
Carcinoma, Head and Neck Neoplasms, Neoplasms, +10 more
Locations
  • Cedars-Sinai Cancer at Beverly Hills (THO) Beverly Hills, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • CS Cancer at Valley Oncology Medical Group Tarzana, California, United States
  • CS Cancer at the Hunt Cancer Center Torrance, California, United States
View Trial Details
Recruiting

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

NCT07227402

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Alaska Oncology and Hematology ( Site 0133) Anchorage, Alaska, United States
  • Providence Medical Foundation ( Site 0141) Fullerton, California, United States
  • Cedars-Sinai Medical Center ( Site 0112) Los Angeles, California, United States
  • New England Cancer Specialists ( Site 0132) Westbrook, Maine, United States
View all 127 locations
View Trial Details
Recruiting

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

NCT07720284

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Research Site Hot Springs, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site San Francisco, California, United States
View all 160 locations
View Trial Details
Recruiting

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

NCT05873686

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +28 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 15 locations
View Trial Details

Related conditions